Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up ...

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...

Led by Bessemer Venture Partners, the highly oversubscribed round comes 18 months after founding, following strong commercial traction and scientific results Despite the momentum, there's still a ...

The MarketWatch News Department was not involved in the creation of this content. Led by Bessemer Venture Partners, the highly oversubscribed round comes 18 months after founding, following strong ...

New York City Mayor Zohran Mamdani has an aspirational hope for his new home at the mayor’s centuries-old official residence. “One thing that we will change is we will be installing a few bidets into ...

Just over ten blocks south of Grand Central Station, in the Cure building, a drug discovery startup named after New York State’s motto—Excelsior, meaning “ever upward”—is aiming to transform ...

Through the creation of human cells and models for research, drug discovery, and toxicology, bit.bio is leading the global transition towards human-relevant New Approach Methodologies 1 (NAMs), which ...

With a lioness-themed rebrand tied to its latest buy, Athira Pharma is roaring into the new year under its second new moniker. The Seattle-based biopharma has chosen LeonaBio as its new name, and will ...

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin.